Wednesday, February 17, 2021 11:47:35 AM
I have not seen the evidence you claim that CRP is the best indicator of severe covid.It is certainly an indicator, but there are many.
For mortality, age remains the single biggest risk factor, with patients in there 80s having mortality 50 times higher than those in their 20s.
You are correct that CRP demonstrates inflammation. The tocilizumab study did select for patients with CRP > 75.
Please recall the clinical correlates (from the paper you noted) for high CRP.
As discussed in the study you noted, CRP (as a measure of inflammation) is a good indicator of inflammation and dysfunction.
Did CD12 exclude patients based on CRP?
No, it did not.
It only limited ARDS to mild and moderate. The claim that CD12 excluded high risk patients is false.
Excluding some high risk patients is not the same as excluding all high risk patients.
As a reminder, the tocilizumab study was open label.
Cytodyn's CD12 leronlimab trial was double-blinded, placebo controlled.
Here are is a nice table summarizing other predictors of mortality.
Looking at this table, CD12 could have restricted patients based on age, liver function, kidney function, hyperkalemia, coagulopathy and hypovolemia.
However, these is a point at which section criteria are sufficiently selective.
Above all, please remember:
Cytodyn CD12 double blinded, placebo controlled
Tocilizumab RECOVERY trial open label
The results of CD12 will be available soon.
As a rigorous, randomized trial, there will be no doubt or conjecture about the results.
They either will or will not be statistically significant. We already know the selected endpoints are clinically significant. There is no endpoint for days to clinical improvement or resolution of myalgia.
As a review, the endpoints are:
Primary:
All-cause mortality at Day 28
Secondary:
All-cause mortality at Day 14
Change in clinical status of subject at Day 14 (on a 7 point ordinal scale)
Change in clinical status of subject at Day 28 (on a 7 point ordinal scale)
Change from baseline in Sequential Organ Failure Assessment (SOFA) score at Day 14.
https://www.clinicaltrials.gov/ct2/show/NCT04347239?term=NCT04347239&draw=2&rank=1
While all of us have our beliefs and expectations of the trial outcome, none of us know yet.
Until then, let's be patient.
Thanks.
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2024 04:15:06 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/07/2024 12:44:56 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/07/2024 12:42:22 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/15/2024 09:21:30 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/22/2024 01:00:58 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:17:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:16:28 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/09/2024 09:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 12:46:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM